A5034940785- Blood Pressure and Hypertension Studies
- Pharmaceutical Practices and Patient Outcomes
- Mental Health and Patient Involvement
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular Disease and Adiposity
- Long-Term Effects of COVID-19
- Primary Care and Health Outcomes
- Cardiac Health and Mental Health
- Health Promotion and Cardiovascular Prevention
- Cardiac, Anesthesia and Surgical Outcomes
- Healthcare cost, quality, practices
- Health Policy Implementation Science
- Diet, Metabolism, and Disease
Kidney Health Australia
2022-2024
Raised blood pressure or hypertension is by far the leading risk factor for preventable deaths in Australia, contributing to over 25 000 annually (Supporting Information, figure 1 and 2),1-3 mainly due stroke, heart disease, kidney failure, atrial fibrillation dementia.3, 4 The reduction of less than 140/90 mmHg only achieved 32% people with control rates have stagnated a decade 3).5, 6 As our compare poorly other high income countries (eg, 68% Canada),5-7 we published call-to-action...
Chronic kidney disease (CKD) is a major cause of morbidity and mortality, contributing to approximately 20 000 deaths in 2021 Australia. Importantly, progression CKD can be substantially reduced if it detected treated early. Here we present the perspectives general practitioner (primary care physician), nephrologist patient advocate on how diagnosis management primary could improved. Early detection treatment are impeded by limited awareness knowledge, communication challenges between...
Introduction Chronic kidney disease (CKD) is increasingly recognised as a growing global public health problem. Early detection and management can significantly reduce the loss of function. The proposed trial aims to evaluate impact community pharmacy-led intervention combining CKD screening medication review on quality use medicines (QUM) for patients with CKD. We hypothesise that will enhance newly diagnosed cases potentially inappropriate medications by people at risk or living Methods...
Abstract The post‐COVID‐19 care era is likely to see a burgeoning of metabolic dysfunction and chronic kidney disease. Attention self‐care, including nutrition, will underpin the management those affected. damaging effects sugar‐sweetened beverages are well documented profound counter many accepted medical treatments. Government leadership urgently required with explicit strong messaging avoid beverages.